287 related articles for article (PubMed ID: 25611786)
1. Quantifying renal allograft loss following early antibody-mediated rejection.
Orandi BJ; Chow EH; Hsu A; Gupta N; Van Arendonk KJ; Garonzik-Wang JM; Montgomery JR; Wickliffe C; Lonze BE; Bagnasco SM; Alachkar N; Kraus ES; Jackson AM; Montgomery RA; Segev DL
Am J Transplant; 2015 Feb; 15(2):489-98. PubMed ID: 25611786
[TBL] [Abstract][Full Text] [Related]
2. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
[TBL] [Abstract][Full Text] [Related]
3. Subclinical Antibody-mediated Rejection After Kidney Transplantation: Treatment Outcomes.
Parajuli S; Joachim E; Alagusundaramoorthy S; Blazel J; Aziz F; Garg N; Muth B; Mohamed M; Mandelbrot D; Zhong W; Djamali A
Transplantation; 2019 Aug; 103(8):1722-1729. PubMed ID: 30507740
[TBL] [Abstract][Full Text] [Related]
4. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
[TBL] [Abstract][Full Text] [Related]
5. Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts.
Haas M; Montgomery RA; Segev DL; Rahman MH; Racusen LC; Bagnasco SM; Simpkins CE; Warren DS; Lepley D; Zachary AA; Kraus ES
Am J Transplant; 2007 Mar; 7(3):576-85. PubMed ID: 17229067
[TBL] [Abstract][Full Text] [Related]
6. One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts.
Dörje C; Mjøen G; Strøm EH; Holdaas H; Jenssen T; Øyen O; Akkök ÇA; Cvancarova M; Midtvedt K; Reisaeter AV
Clin Transplant; 2015 Mar; 29(3):268-76. PubMed ID: 25644963
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study.
Lonze BE; Bae S; Kraus ES; Holechek MJ; King KE; Alachkar N; Naqvi FF; Dagher NN; Sharif A; Desai NM; Segev DL; Montgomery RA
Transpl Int; 2017 Sep; 30(9):874-883. PubMed ID: 28403566
[TBL] [Abstract][Full Text] [Related]
8. HLA-DQ Mismatches and Rejection in Kidney Transplant Recipients.
Lim WH; Chapman JR; Coates PT; Lewis JR; Russ GR; Watson N; Holdsworth R; Wong G
Clin J Am Soc Nephrol; 2016 May; 11(5):875-883. PubMed ID: 27034399
[TBL] [Abstract][Full Text] [Related]
9. Influences of Pre-formed Donor-Specific Anti-Human Leukocyte Antigen Antibodies in Living-Donor Renal Transplantation: Results With Graft Immunocomplex Capture Fluorescence Analysis.
Nakamura T; Ushigome H; Watabe K; Imanishi Y; Masuda K; Matsuyama T; Harada S; Koshino K; Iida T; Nobori S; Yoshimura N
Transplant Proc; 2017 Jun; 49(5):955-958. PubMed ID: 28583566
[TBL] [Abstract][Full Text] [Related]
10. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
[TBL] [Abstract][Full Text] [Related]
11. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
[TBL] [Abstract][Full Text] [Related]
12. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
[TBL] [Abstract][Full Text] [Related]
13. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
[TBL] [Abstract][Full Text] [Related]
14. Transfusion of leukoreduced blood products and risk of antibody-mediated rejection of renal allografts.
Bynum JP; Zachary A; Ness PM; Luo X; Bagnasco S; King KE; Segev DL; Orandi BJ; Warren DS; Fuller A; Ciappi A; Montgomery R; Tobian AAR
Transfusion; 2018 Aug; 58(8):1951-1957. PubMed ID: 30171817
[TBL] [Abstract][Full Text] [Related]
15. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
Masutani K; Tsuchimoto A; Kurihara K; Okabe Y; Kitada H; Okumi M; Tanabe K; Nakamura M; Kitazono T; Tsuruya K;
Transplantation; 2017 Jun; 101(6):1416-1422. PubMed ID: 27391195
[TBL] [Abstract][Full Text] [Related]
16. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.
Fidler S; Swaminathan R; Lim W; Ferrari P; Witt C; Christiansen FT; D'Orsogna LJ; Irish AB
Transpl Immunol; 2013 Dec; 29(1-4):22-7. PubMed ID: 24090807
[TBL] [Abstract][Full Text] [Related]
17. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE
Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362
[TBL] [Abstract][Full Text] [Related]
18. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients.
Sharif A; Alachkar N; Bagnasco S; Geetha D; Gupta G; Womer K; Arend L; Racusen L; Montgomery R; Kraus E
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1320-7. PubMed ID: 22626962
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
20. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.
Sicard A; Ducreux S; Rabeyrin M; Couzi L; McGregor B; Badet L; Scoazec JY; Bachelet T; Lepreux S; Visentin J; Merville P; Fremeaux-Bacchi V; Morelon E; Taupin JL; Dubois V; Thaunat O
J Am Soc Nephrol; 2015 Feb; 26(2):457-67. PubMed ID: 25125383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]